Bange, E., Marmarelis, M. E., Hwang, W., Yang, Y., Thompson, J. C., Rosenbaum, J., . . . Aggarwal, C. (2019). Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non–Small-Cell Lung Cancer. JCO Precis Oncol.
Citação norma ChicagoBange, Erin, et al. "Impact of KRAS and TP53 Co-Mutations On Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non–Small-Cell Lung Cancer." JCO Precis Oncol 2019.
Citação norma MLABange, Erin, et al. "Impact of KRAS and TP53 Co-Mutations On Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non–Small-Cell Lung Cancer." JCO Precis Oncol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.